about
Optimization of long circulating mixed polymeric micelles containing vinpocetine using simple lattice mixture design, in vitro and in vivo characterization.Multiplexed integrating plasmids for engineering of the erythromycin gene cluster for expression in Streptomyces spp. and combinatorial biosynthesis.Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.Comparative pharmaceutical study on colon targeted micro-particles of celecoxib: in-vitro-in-vivo evaluation.Novel chewable sustained-release tablet containing verapamil hydrochloride.Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.Fluconazole mucoadhesive buccal films: in vitro/in vivo performance.Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats.Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: in-vitro optimization and in-vivo performance in humans.Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model.Chitosan lactate wafer as a platform for the buccal delivery of tizanidine HCl: in vitro and in vivo performance.Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.The Impact of Amorphisation and Spheronization Techniques on the Improved in Vitro & in Vivo Performance of Glimepiride Tablets.Hot-melts in buccoadhesive patches: an approach for bioavailability enhancement of highly-metabolized drugs with short elimination half-life.Utilization of ionotropic gelation technique for bioavailability enhancement of cinnarizine: in-vitro optimization and in-vivo performance in human.Effect of formulation variables on design, in vitro evaluation of valsartan SNEDDS and estimation of its antioxidant effect in adrenaline-induced acute myocardial infarction in rats.Characterization and evaluation of tenoxicam coprecipitatesBaclofen novel gastroretentive extended release gellan gum superporous hydrogel hybrid system: in vitro and in vivo evaluationSuperhydrophobic Substrates for Ultrahigh Encapsulation of Hydrophilic Drug into Controlled-Release Polyelectrolyte Complex Beads: Statistical Optimization and In Vivo EvaluationTripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular SystemIntegrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluationCore-in-cup/liquisol dual tackling effect on azelnidipine buccoadhesive tablet micromeritics, in vitro release, and mucoadhesive strength
P50
Q35309308-4497A139-6B9A-49F8-9DD6-10F73F660E5CQ36279519-7CCDEC12-F562-46E4-81C9-82D2D981B25CQ38312135-137E5F57-A920-402A-BD08-3E70759B0461Q38880054-D31DAB94-611B-48AA-A072-620D2660E613Q44940513-BEAA8070-CA44-462B-A45C-3D8B1A17EC8CQ45259769-4BC27326-174E-46B7-8BE8-C8E3326815EBQ46023967-CD31161C-8110-417E-9AFF-1137871A20F9Q46228796-C6279FD8-E917-4C4E-B53C-FE67B57DDB70Q46626234-8FE0D065-E4FB-4AD5-945D-7E44D5340F40Q46647863-93509DE7-42EE-4E13-890F-9BF935CA485CQ46794012-2888052D-FFA9-4E59-B9AF-249EB0815A9BQ46812676-621F9400-1D16-4FEC-8401-C4995062E414Q46902877-2D0DA487-527E-4F73-A8A0-A75850DE791DQ49265974-CB043C5D-0992-487A-9714-6336FF27018CQ53374342-914DDBA5-5282-4A8A-AC2F-65CB759D7103Q53430725-22585118-2AAD-4EB1-A281-F361FF13EA56Q55043887-DCBE5A07-A011-4641-9E47-CBC0147DECAEQ74065414-998218DE-1FAD-4344-8325-09379B2DA4A7Q87791216-EE1EC4B8-E33E-4D18-B4F5-C56D5D8EC84BQ92495101-485AFE4E-A1C9-4D3B-BEC1-14E4F2850DE7Q92853421-33074537-EFCD-421B-84DB-23A6F442B9B9Q92986012-D5ED833E-E415-456B-9B0E-9959F76E8898Q93156287-DD137623-9F8B-49DF-B86F-EA8354BB1CFF
P50
description
researcher
@en
name
Omaima N El-Gazayerly
@en
Omaima N El-Gazayerly
@nl
type
label
Omaima N El-Gazayerly
@en
Omaima N El-Gazayerly
@nl
prefLabel
Omaima N El-Gazayerly
@en
Omaima N El-Gazayerly
@nl
P106
P31
P496
0000-0001-8475-0412